Beijing Philisense Technology Co., Ltd. (SHE:300287)

Ligand Pharmaceuticals Revenue

Beijing Philisense Technology had revenue of 115.54M CNY in the quarter ending March 31, 2025, a decrease of -27.14%. This brings the company's revenue in the last twelve months to 541.93M, down -19.72% year-over-year. In the year 2024, Beijing Philisense Technology had annual revenue of 584.98M, down -28.96%.

• Revenue (ttm): 541.93M
• Revenue Growth: -19.72%
• P/S Ratio: 14.54
• Revenue / Employee: 656.09K
• Employees: 826
• Market Cap: 7.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	584.98M	-238.48M	-28.96%
Dec 31, 2023	823.46M	-319.50M	-27.95%
Jan 1, 2023	1.14B	-566.96M	-33.16%
Jan 1, 2022	1.71B	738.25M	75.98%
Dec 31, 2020	971.67M	-500.68M	-34.01%